Wolowacz S, Briggs A, Lloyd AJ, Doward L. Collecting health-state utility estimates for economic models in clinical studies. Presented at the 2016 ISPOR 19th Annual European Congress; October 29, 2016. Vienna, Austria.
Wolowacz SE, Briggs A, Belozeroff V, Clarke P, Doward L, Goeree R, Lloyd A, Norman R. Estimating health-state utility for economic models in clinical studies: an ISPOR good research practices task force report. Value Health. 2016 Sep;19(2016):704-19. doi: 10.1016/j.jval.2016.06.001
McKenna SP, Meads DM, Doward LC. Scaling properties of the Dermatology Life Quality Index (DLQI). Poster presented at the 2004 ISPOR 7th Annual European Congress; November 2004. Hamburg, Germany. [abstract] Value Health. 2004 Nov; 7(6):750-1.
Meads DM, Doughty NJ, McKenna SP, Doward LC, Pepke-Zaba J. Disease specific versus generic outcome assessment in pulmonary hypertension. Poster presented at the 2004 ISPOR 7th Annual European Congress; November 2004. Hamburg, Germany. [abstract] Value Health. 2004 Nov; 7(6):701-2.
Meads DM, McKenna SP, Doughty NJ, Doward LC, Pepke-Zaba J. Validation of the pulmonary hypertension outcome review (CAMPHOR) questionnaire. Poster presented at the 2004 ISPOR 7th Annual European Congress; November 2004. Hamburg, Germany. [abstract] Value Health. 2004 Nov; 7(6):700-1.
McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. The development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis. 2004 Feb 1;63(2):162-9.
Whalley D, Doward LC, Dewar AL, McKenna SP, Tennant A, Emery P. The development of a quality of life measure specific to psoriatic arthritis. Poster presented at the 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL); November 1999. Barcelona, Spain. [abstract] Qual Life Res. 1999 Nov; 8(7):652.
Doward LC, Whalley D, Dewar AL, McKenna SP, Tennant A, Emery P. The development of the SLE-QoL: a quality of life instrument specific to systemic lupus erythematosus. Poster presented at the 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL); November 1999. Barcelona, Spain. [abstract] Qual Life Res. 1999 Nov; 8(7):609.
McKenna SP, Doward LC. A review of quality of life in Alzheimer's disease. Parts 1 and 2: issues in assessing disease impact and drug effects. Pharmacoeconomics. 1999 Oct;16(4):417-9.
Helliwell PS, Doward L, Whalley D, Tennant A, McKenna S, Reynolds S, Kay L, Spoorenberg A, van der Heijde Leeds D. Psychometric and scaling properties of a new quality of life instrument specific to ankylosing spondylitis (AS). Poster presented at the 1999 ACR/ARHP Annual Scientific Meeting; November 14, 1999. Boston, MA. [abstract] Arthritis Rheumatol. 1999 Sep; 42(S9):s72.
McKenna SP, Whalley D, Renck-Hooper U, Carlin S, Doward LC. The development of a quality of life instrument for use with post-menopausal women with urogenital atrophy in the UK and Sweden. Qual Life Res. 1999 Aug;8(5):393-8.
McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L, Wiren L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res. 1999 Jun;8(4):373-83.
McKenna SP, Doward LC. Quality-of-life assessment of adults with growth hormone deficiency: implications for drug therapy. Pharmacoeconomics. 1994 Nov 1;6(5):434-41.
Doward LC. Developing a measure of quality of life for patients with recurrent genital herpes. Drug Inf J. 1994 Jan 1;28(1):19-25.